Cargando…
The TB vaccine development pathway – An innovative approach to accelerating global TB vaccine development
Two proof of concept clinical trials with TB vaccines demonstrate that new approaches can prevent sustained TB infection in adolescents (BCG revaccination) and TB disease in adults (M72/ASO1(E)) (Nemes et al., 2018; Tait et al., 2019) [1,2]. Both approaches are in late stage development and provide...
Autores principales: | Roordink, Danielle, Williams, Ann, Fritzell, Bernard, Laddy, Dominick J., Gerdil, Emmanuelle, Graffin, Anne Marie, Tait, Dereck, van der Pol, Leo, van den Brink, Ilona, Holleman, Marit, Thole, Jelle, Voss, Gerald, Lempicki, Maria, Thiry, Georges |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Churchill Livingstone
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896101/ https://www.ncbi.nlm.nih.gov/pubmed/33310626 http://dx.doi.org/10.1016/j.tube.2020.102040 |
Ejemplares similares
-
Progress and challenges in TB vaccine development
por: Voss, Gerald, et al.
Publicado: (2018) -
TB vaccine development and the End TB Strategy: importance and current status
por: Fletcher, Helen A., et al.
Publicado: (2016) -
Immunologic goalposts for TB vaccine development
por: Um, Peter K., et al.
Publicado: (2021) -
109 Problems and prospects of development of the subunit TB vaccine
por: Tkachuk, A.B., et al.
Publicado: (2014) -
Ending the TB pandemic: the urgency of a new and improved TB vaccine and the World Health Organization's TB Vaccine Accelerator Council
por: Adepoju, Victor Abiola, et al.
Publicado: (2023)